Skip to content
Search

Latest Stories

CPE chief executive Janet Morrison recalls community pharmacy’s 2023 highs and lows

CPE chief executive Janet Morrison recalls community pharmacy’s 2023 highs and lows

Janet believes pharmacy first service and expansion of contraception and blood pressure checking services are a big step forwards for community pharmacies.

Community Pharmacy England (CPE) chief executive Janet Morrison has reflected on the highs and lows of the sector from the past 12 months in her end of year blog published on Wednesday.


Janet is proud of what the sector has achieved in 2023, including the huge number of services delivered for patients despite ongoing pressures, the agreement of a national Pharmacy First service and the most significant investment in community pharmacy for well over a decade.

But she also pointed that that the past year has been extremely tough for pharmacy owners and their teams as they battle immense financial and operational challenges, resulting in recent wave of consolidations and closures across the sector.

Community Pharmacy England CPE chief executive Janet Morrison 1

Photo credit:CPE

Speaking about community pharmacy’s 2023 lows, she cited their 2023 Pharmacy Pressures Survey, which found that the majority (96 per cent) of pharmacy owners were facing significantly higher costs than the previous year.

While 97 per cent of them reported significant increases in wholesaler and medicine supply issues, 92 per cent had seen a big rise in requests from patients unable to access General Practice, according to the survey.

Acknowledging that it's hard to be optimistic about the future in the current pressurised atmosphere, Janet identifies some glimmers of hope such as the Vision for Community Pharmacy, the Pharmacy Inquiry by the Parliamentary Health and Social Care Committee, as well as the new Pharmacy First service.

She wrote: “The Vision for Community Pharmacy, developed by leading the influential healthcare think tanks Nuffield Trust and The King’s Fund, has set out a bold plan for the sector. It has provided us with a powerful influencing tool and the implications of this are being considered alongside the wider development of a strategy for Community Pharmacy England.

“This work, coupled with a Pharmacy Inquiry by the Parliamentary Health and Social Care Committee, will prove critical in determining how we can transform community pharmacy to become what the public, the NHS, and the Government need it to be.

“And then there is the new Pharmacy First service – the most strategically significant service in many years. £645 million is a critical injection of funding and a welcome vote of confidence in our future from Government and the NHS.”

She believes that the introduction of Pharmacy First and expansion of contraception and blood pressure checking services are a big step forwards for local pharmacies and their patients.

Highlighting that many pharmacies struggling to stay afloat due to lack of fund, Janet's end of year blog underscored the need for a significant increase to the core funding contract.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less